<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Second Company IT</provider_name><provider_url>https://www.secondcompany.nl/en/</provider_url><author_name>Jurjen Smakman</author_name><author_url>https://www.secondcompany.nl/en/blog/author/diffuse/</author_url><title>Transformation disruptive player in medical industry - Second Company IT</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="mVfryq7tAU"&gt;&lt;a href="https://www.secondcompany.nl/en/cases/providing-early-access-to-medicines/"&gt;Transformation disruptive player in medical industry&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.secondcompany.nl/en/cases/providing-early-access-to-medicines/embed/#?secret=mVfryq7tAU" width="600" height="338" title="&#x201C;Transformation disruptive player in medical industry&#x201D; &#x2014; Second Company IT" data-secret="mVfryq7tAU" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.secondcompany.nl/wp/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><thumbnail_url>https://www.secondcompany.nl/app/uploads/2019/10/myTomorrows.png</thumbnail_url><thumbnail_width>1126</thumbnail_width><thumbnail_height>601</thumbnail_height><description>10 years or more. That is how long it can take for a drug to be approved. Often doctors and their patients do not have access to the drug in the period before approval, while it may already be showing promising results. MyTomorrows wants to prevent patients from missing out on treatment options due to &hellip; Continued</description></oembed>
